Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation

Post-transplantation cyclophosphamide (PTCy) is an effective strategy to prevent graft-versus-host disease (GVHD) after haploidentical haematopoietic cell transplantation (HCT). We determined the efficacy of PTCy-based GVHD prophylaxis in human leucocyte antigen (HLA)-mismatched unrelated donor (MMU...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Br J Haematol
Auteurs principaux: Mehta, Rohtesh S., Saliba, Rima M., Chen, Julianne, Rondon, Gabriela, Hammerstrom, Aimee E., Alousi, Amin, Qazilbash, Muzaffar, Bashir, Qaiser, Ahmed, Sairah, Popat, Uday, Hosing, Chitra, Khouri, Issa, Shpall, Elizabeth J., Champlin, Richard E., Ciurea, Stefan O.
Format: Artigo
Langue:Inglês
Publié: 2016
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5459488/
https://ncbi.nlm.nih.gov/pubmed/26947769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.13977
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires